| pubmed-article:12105256 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12105256 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
| pubmed-article:12105256 | lifeskim:mentions | umls-concept:C0184511 | lld:lifeskim |
| pubmed-article:12105256 | lifeskim:mentions | umls-concept:C0676831 | lld:lifeskim |
| pubmed-article:12105256 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:12105256 | lifeskim:mentions | umls-concept:C0003370 | lld:lifeskim |
| pubmed-article:12105256 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:12105256 | pubmed:dateCreated | 2002-7-9 | lld:pubmed |
| pubmed-article:12105256 | pubmed:abstractText | Basiliximab is a chimeric human/mouse monoclonal antibody directed against the alpha chain of the IL-2 receptor, CD25, which has been reported as successfully reducing rejection in adult renal transplant recipients. Reported clinical experience of basiliximab in paediatric renal transplantation is limited. | lld:pubmed |
| pubmed-article:12105256 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12105256 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12105256 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12105256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12105256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12105256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12105256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12105256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12105256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12105256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12105256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12105256 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12105256 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12105256 | pubmed:issn | 0931-0509 | lld:pubmed |
| pubmed-article:12105256 | pubmed:author | pubmed-author:ClarkGodfreyG | lld:pubmed |
| pubmed-article:12105256 | pubmed:author | pubmed-author:WalshGráinneG | lld:pubmed |
| pubmed-article:12105256 | pubmed:author | pubmed-author:DeshpandePank... | lld:pubmed |
| pubmed-article:12105256 | pubmed:author | pubmed-author:KoffmanGeoffG | lld:pubmed |
| pubmed-article:12105256 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12105256 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:12105256 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12105256 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12105256 | pubmed:pagination | 1304-9 | lld:pubmed |
| pubmed-article:12105256 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:meshHeading | pubmed-meshheading:12105256... | lld:pubmed |
| pubmed-article:12105256 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12105256 | pubmed:articleTitle | Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. | lld:pubmed |
| pubmed-article:12105256 | pubmed:affiliation | Department of Paediatric Nephrology, Guy's Hospital, London, UK. godfrey.clark@kcl.ac.uk | lld:pubmed |
| pubmed-article:12105256 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12105256 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12105256 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12105256 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12105256 | lld:pubmed |
